Provera and Aricept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Provera (medroxyprogesterone acetate) and Aricept (donepezil hydrochloride). Common drug interactions include electrocardiogram qt prolonged among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Provera and Aricept. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Provera?

Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 54,943 Provera users. Check the latest studies of Provera.

What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.



On Jul, 08, 2026

44 people who take Provera and Aricept together, and have interactions are studied.

Provera and Aricept drug interactions.

What are the common drug interactions of Provera and Aricept, by gender? *:

female:

  1. Electrocardiogram qt prolonged
  2. Sedation
  3. Speech disorder
  4. Depressed level of consciousness
  5. Depression
  6. Asthenia (weakness)
  7. Lethargy (tiredness)
  8. Abdominal pain upper
  9. Acute hepatic failure
  10. Autoimmune hepatitis

male:

  1. Fall
  2. Asthenia (weakness)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Application site erythema (redness of the skin at application site)
  5. Application site reaction
  6. Blood glucose increased
  7. Blood urea increased
  8. Lymphocyte count decreased
  9. Lymphocyte percentage decreased
  10. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

What are the common drug interactions of Provera and Aricept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  2. Productive cough

40-49:

  1. Asthenia (weakness)
  2. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Depression
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Fall
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Unresponsive to stimuli
  10. Electrocardiogram st segment elevation

50-59:

  1. Electrocardiogram qt prolonged
  2. Acute hepatic failure
  3. Autoimmune hepatitis
  4. Coma hepatic (accumulation in the bloodstream of toxic substances that are normally removed by the liver leads coma)
  5. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  6. Asthenia (weakness)
  7. Atrioventricular dissociation (av block)
  8. Confusional state
  9. Cough
  10. Diarrhoea

60+:

  1. Speech disorder
  2. Depressed level of consciousness
  3. Anaemia (lack of blood)
  4. Application site erythema (redness of the skin at application site)
  5. Application site reaction
  6. Asthenia (weakness)
  7. Ataxia (loss of full control of bodily movements)
  8. Breast cancer female
  9. Colon cancer
  10. Confusion

What are the existing conditions these people have? *

  1. Sleep Disorder: 15 people, 34.09%
  2. Constipation: 15 people, 34.09%
  3. Depression: 11 people, 25.00%
  4. Stress And Anxiety: 9 people, 20.45%
  5. Fever: 8 people, 18.18%
  6. Pain: 8 people, 18.18%
  7. Nausea (feeling of having an urge to vomit): 8 people, 18.18%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 18.18%
  9. Lymphangioleiomyomatosis (a rare lung condition that affects a certain type of muscle cell and only occurs in women): 7 people, 15.91%
  10. Dementia (madness): 7 people, 15.91%

* Approximation only. Some reports may have incomplete information.

Do you take Provera and Aricept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Provera and Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Provera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aricept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate and donepezil hydrochloride (the active ingredients of Provera and Aricept, respectively), and Provera and Aricept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: